On heels of FDA approval for its CBD epilepsy drug, GW Pharm continues focus on schizophrenia & other “incurable” diseases

Drug company earning multi-millions on MS med containing only 2 ingredients – THC and CBD ready to launch epilepsy drug this fall & now racing to develop CBD drugs for schizophrenia, #autism & other hard-to treat diseases. Continue reading On heels of FDA approval for its CBD epilepsy drug, GW Pharm continues focus on schizophrenia & other “incurable” diseases

Sticky post

Man-made THC improves headache in clinical trials

Clues to the anti-headache mechanisms of cannabis can be found by looking at headache conditions that are relieved by reducing intracranial pressure.  Dexanabinol, a synthetic cannabinoid, has been found to relieve intracranial pressure and improve outcomes after traumatic brain injury. In addition, a double-blind, placebo-controlled trial of 26 patients found that a synthetic form of THC (Nabilone) was “significantly more effective” than Ibuprofen in reducing pain intensity. It was also suggested that the anti-vomiting properties seen in the treatment of nausea brought on by chemotherapy might also be effective in treating migraine. Copyright Notice ©CannabisFindings.com. 2018. Unauthorized use and/or duplication … Continue reading Man-made THC improves headache in clinical trials